WNS Holdings (WNS) Rallies for 7th Day on $3.3-Billion Acquisition
WNS Holdings extended its winning streak to a 7th straight day on Monday, jumping 14.26 percent to close at $74.7 apiece following news that it was set to be acquired by Capgemini for $3.3 billion.
In a statement, Capgemini said that it entered into a definitive agreement with WNS (Holdings) Limited (NYSE:WNS) for the acquisition of a significant stake in the latter at a price of $76.5 apiece.
Capgemini said that the acquisition price represents a premium of 28 percent to the last 90-day average share price; of 27 percent to the last 30-day average share price; and a premium of 17 percent to the last closing share price on July 3, 2025.
'As a recognized leader in the Digital Business Process Services space, we see the next wave of transformation being driven by intelligent, domain-centric operations that unlock strategic value for our clients,' said WNS (Holdings) Limited (NYSE:WNS) CEO Keshav Murugesh.
An IT professional working with a laptop in a modern, urban office.
'By combining our deep domain and process expertise with Capgemini's global reach, cutting-edge Gen AI and Agentic AI capabilities, a robust partner ecosystem, and advanced technology platforms, we are creating a powerful proposition that accelerates enterprise reinvention,' he added.
While we acknowledge the potential of WNS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the .
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This article is originally published at Insider Monkey.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hill
a minute ago
- The Hill
Trump taps conservative economist EJ Antoni to serve as next labor statistics chief
President Trump on Monday announced he would nominate E.J. Antoni, a top economist at the conservative Heritage Foundation, to serve as the next commissioner of the Bureau of Labor Statistics after he pushed out the previous leader. 'Our Economy is booming, and E.J. will ensure that the Numbers released are HONEST and ACCURATE,' Trump posted on Truth Social. 'I know E.J. Antoni will do an incredible job in this new role. Congratulations E.J.!' Antoni is the chief economist at the Heritage Foundation and previously contributed to Project 2025's policy rubric, which outlined potential moves for the next GOP administration during the 2024 campaign. Antoni has in the past expressed skepticism about data from the Bureau of Labor Statistics. He recently appeared on conservative firebrand Steve Bannon's podcast to urge Trump to fire the previous commissioner, Erika McEntarfer. The position requires Senate confirmation, but Republicans hold a 53-47 GOP majority, giving Antoni a path to the job even if there are defections. Trump earlier this month ordered the firing of McEntarfer, a Biden White House appointee who was confirmed with a large bipartisan majority in the Senate in 2024. The move came after the jobs report released in early August showed lower-than-expected hiring in July and major downward revisions to the jobs reports from May and June. While Trump and his allies argued it was a move intended to improve transparency and accuracy, critics noted McEntarfer had little to do with what the numbers showed. Economists and lawmakers also expressed concern that it would erode credibility and confidence in government data, hurting businesses and consumers in the process.
Business Wire
a minute ago
- Business Wire
Zoetis Announces Pricing of $1.85 Billion of Senior Notes
PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced that it has agreed to sell $1.850 billion of senior notes, consisting of $850.0 million aggregate principal amount of 4.150% senior notes due 2028 and $1.0 billion aggregate principal amount of 5.000% senior notes due 2035, in an underwritten public offering. Zoetis intends to use the net proceeds to repay the principal of (i) its 4.500% senior notes due 2025 in the aggregate principal amount of $750 million, (ii) its 5.400% senior notes due 2025 in the aggregate principal amount of $600 million, and (iii) the remainder for general corporate purposes. The offering is expected to close on August 18, 2025, subject to customary closing conditions. Barclays Capital Inc., BofA Securities, Inc., Citigroup Global Markets Inc., J.P. Morgan Securities LLC and MUFG Securities Americas Inc. are acting as joint book-running managers of the underwriters. The final prospectus supplement and accompanying prospectus, when available, may be accessed through the SEC's website at Alternatively, the issuer, the underwriters or any dealer participating in the offering will arrange to send the prospectus and prospectus supplement upon request by calling Barclays at 1-888-603-5847, BofA Securities at 1-800-294-1322, Citigroup at 1-800-831-9146, J.P. Morgan at 212-834-4533 and MUFG at 1-877-649-6848. These securities are offered pursuant to a registration statement that has become effective under the Securities Act of 1933, as amended. These securities are only offered by means of the prospectus supplement and prospectus relating to the offering. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any offer or sale of these securities in any state or other jurisdiction, where the offer, solicitation or sale of these securities would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction. About Zoetis As the world's leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock producers. The company's leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. DISCLOSURE NOTICES Forward-Looking Statements: This press release contains forward-looking statements, which reflect the current views of Zoetis with respect to: business plans or prospects, future operating or financial performance, future guidance, future operating models; R&D costs; timing and likelihood of success; expectations regarding products, product approvals or products under development and expected timing of product launches; expectations regarding competing products; expectations regarding financial impact of divestitures; disruptions in our global supply chain; expectations regarding the performance of acquired companies and our ability to integrate new businesses; expectations regarding the financial impact of acquisitions; future use of cash, dividend payments and share repurchases; foreign exchange rates, tax rates, tariffs, changes in tax regimes and laws and any changes thereto; and other future events. These statements are not guarantees of future performance or actions. Forward-looking statements are subject to risks and uncertainties. If one or more of these risks or uncertainties materialize, or if management's underlying assumptions prove to be incorrect, actual results may differ materially from those contemplated by a forward-looking statement. Forward-looking statements speak only as of the date on which they are made. Zoetis expressly disclaims any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. A further list and description of risks, uncertainties and other matters can be found in our most recent Annual Report on Form 10-K, including in the sections thereof captioned 'Forward-Looking Statements and Factors That May Affect Future Results' and 'Item 1A. Risk Factors,' in our Quarterly Reports on Form 10-Q and in our Current Reports on Form 8-K. These filings and subsequent filings are available online at or on request from Zoetis.
Business Wire
a minute ago
- Business Wire
Marcus & Millichap Capital Corporation Secures $91M in Construction Financing for Two Multifamily Projects in Southwest Florida
NAPLES, Fla.--(BUSINESS WIRE)-- Marcus & Millichap Capital Corporation (MMCC), a leading provider of commercial real estate capital markets financing solutions, has arranged $91.4 million in financing for the construction of two multifamily assets in Naples, Florida: Vintana at Vanderbilt, a 150-unit apartment property, and The Karlyn, a 159-unit, active adult community for residents aged 55 and older. Marcus & Millichap Capital Corporation Secures $91M in Construction Financing for Two Multifamily Projects in Southwest Florida Share Gary Sefcik, based in MMCC's Manhattan office, secured the financing. The capital stack includes $78.9 million in senior debt provided by Kayne Anderson and $12.5 million in mezzanine financing from SteepRock Capital on behalf of the sponsor, Roers Companies. Vintana at Vanderbilt, located at 3375 Vanderbilt Beach Road, is adjacent to the Ritz-Carlton golf course and within a short drive of renowned Naples beaches. The Karlyn, at 7576 Immokalee Road, is also near the Gulf Coast shoreline. Both projects are slated for completion in 2027 and will feature high-end finishes and resort-style amenities. 'The financing package demonstrates that lenders remain eager to aggressively pursue Florida multifamily projects when strong sponsorship is combined with a compelling submarket story,' said Sefcik. 'Ranked as the No. 1 place to live in the United States, Naples has high barriers to entry, stringent zoning regulations and limited availability of multifamily-zoned sites.' About Marcus & Millichap Capital Corporation Marcus & Millichap Capital Corporation (MMCC) is a subsidiary of Marcus & Millichap (NYSE:MMI), a leading commercial real estate investment services firm with offices throughout the United States and Canada. MMCC provides commercial real estate capital markets financing solutions, including debt, mezzanine financing, preferred and joint venture equity, sponsor equity, loan sales and consultative and due diligence services. In 2024, MMCC closed 1,249 transactions totaling $9.1 billion. To learn more, please visit: About Marcus & Millichap, Inc. (NYSE:MMI) Marcus & Millichap, Inc. is a leading brokerage firm specializing in commercial real estate investment sales, financing, research and advisory services with offices throughout the United States and Canada. Marcus & Millichap closed 7,836 transactions with a sales volume of approximately $49.6 billion in 2024. The company had 1,712 investment sales and financing professionals in more than 80 offices who provide investment brokerage and financing services to sellers and buyers of commercial real estate at year end. For additional information, please visit
